Wings for Life

Axonis Therapeutics is a biotechnology company focused on neurological disorders. It develops medicines targeting KCC2, a critical mediator of inhibition within the brain, using a proprietary neuron-specific K-Cl cotransporter (KCC2) discovery engine. The company aims to improve lives by treating conditions such as epilepsy and pain.

ReNetX Bio is a biotechnology company focused on developing therapeutics to treat injury and damage to the central nervous system. It advances disease-modifying programs including Nogo Trap, a decoy receptor that blocks growth inhibitors to promote axonal regeneration, sprouting, and synaptic plasticity, with aims to restore function after spinal cord injury, stroke, and glaucoma. The company develops small-molecule oral compounds designed to intervene in CNS pathology by disrupting harmful protein interactions, such as blocking the binding of beta-amyloid oligomers to prion protein to support axonal regrowth. Based in New Haven, Connecticut, ReNetX Bio pursues therapies intended to address CNS conditions by promoting nerve fiber regrowth and functional recovery. The pipeline emphasizes treatments that modify disease progression and support neural repair after injury and in neurodegenerative contexts.